Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Taylor WJ et al. - A short list of features has been identified and now requires validation against a patient- and physician-defined gout flare in order to determine the best combination of features.

Related Articles

New Phase II data show ACZ885 gave better pain relief and flare prevention for patients with chronic gout than an injectable corticosteroid
Novartis, 10/21/09    Relevance Score: 66%

Safer colchicine dosing regimen approved
American Pharmacists Association, 10/08/09    Relevance Score: 64%

Prevalence of flare and influence of demographic and serologic factors on flare risk in systemic lupus erythematosus: A prospective study
Journal of Rheumatology, 10/20/09    Relevance Score: 48%

Outcome Domains for Studies of Acute and Chronic Gout
Journal of Rheumatology, 10/20/09    Relevance Score: 46%

The impact of carcinoembryonic antigen flare in patients with advanced colorectal cancer receiving first-line chemotherapy
Annals of Oncology, 11/03/09    Relevance Score: 45%

Today in Gout and Hyperuricemia...keeping you current

Crystal-induced neutrophil activation
Immunology & Cell Biology, 12/08/09

Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease
PLoS ONE - Cardiovascular Disorders, 11/10/09

The modern management of gout
Rheumatology, 10/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address